Patents

US 12673073 B2: FasL-engineered biomaterials with immunomodulatory function

Granted
2026-07-07
Filed
2023-01-20 application 18157633
Type
Utility · 20 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Described herein are FasL-engineered biomaterials, as well as methods of making and using such FasL-engineered biomaterials, such as for immunomodulation, such as for inducing immunosuppression and specific immune tolerance, such as for preventing or reducing the risks of rejection of cellular or tissue grafts and/or the treatment of autoimmune disorders such as Type I diabetes. In specific embodiments, the FasL-engineered biomaterials are biotinylated microgels bound to SA-FasL.

Source: PTBLXML, file of 2026-07-07 (ipgb20260707.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
University of Louisville Research Foundation, Inc. 342 patentsUS company or organizationLouisville, KYUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INC Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-07-07
Georgia Tech Research Corporation 1,417 patentsUS company or organizationAtlanta, GAGEORGIA TECH RESEARCH CORPORATION State business registration EXACT high confidence: identical full name and state
GEORGIA TECH RESEARCH CORPORATION Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-07-07

Inventors

InventorPlacePatentsPerson pageSource
Haval ShirwanLouisville, KY12PTBLXML, file of 2026-07-07
Andres J. GarciaAtlanta, GA18PTBLXML, file of 2026-07-07
Esma S. YolcuLouisville, KY6PTBLXML, file of 2026-07-07
Hong ZhaoLouisville, KY29PTBLXML, file of 2026-07-07
Devon HeadenAtlanta, GA3PTBLXML, file of 2026-07-07

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/39PTBLXML, file of 2026-07-07
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/08PTBLXML, file of 2026-07-07
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/85PTBLXML, file of 2026-07-07

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.